Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01378208
Other study ID # VEK-H-3-2011-023
Secondary ID
Status Completed
Phase N/A
First received June 15, 2011
Last updated November 19, 2013
Start date June 2011
Est. completion date June 2013

Study information

Verified date November 2013
Source Rigshospitalet, Denmark
Contact n/a
Is FDA regulated No
Health authority Denmark: The Danish National Committee on Biomedical Research Ethics for the Capital RegionDenmark: Danish Dataprotection Agency
Study type Interventional

Clinical Trial Summary

The Danish Food Administration recommends eating three main meals and three small meals a day in order to maintain a healthy lifestyle. However, there is little research to support this concept- moreover, many studies shows that fasting can have a positive impact on our health.

HYPOTHESIS AND PURPOSE The investigators hypothesize, that the number of meals per day in order to maintain a healthy lifestyle will not differ in normal weight subjects.

The investigators will include 1) healthy, normal weight subjects. The investigators will study the effects of two daily meals.

More specifically, the investigators want to better understand how the body reacts to long-term, intermittent fasting (14 h /day for 4 weeks). The investigators will assess cognitive function, dietary intake, appetite regulation, fitness, glucose and insulin responses, as well as fat and muscle composition of the body before, during, and after the study.

Our long-term goals are to compare the effects of intermittent fasting with acute fasting. All of this is in an effort to establish how our eating habits ultimately affect our health and to, perhaps, contribute to new recommendations for healthy eating in normal weight population.

BACKGROUND Obesity and diabetes are increasing health threats facing the Western world today, despite abundant research efforts and campaigns to prevent such outcomes. Throughout the years, as the incidence of both obesity and diabetes in the general population has increased, so too has the typical number of daily meals. A once common three meals per day has now increased to six meals per day, in many instances. Recent animal research has shown that intermittent fasting (one or two meals per day) over a long period of time can improve cardiovascular health and prevent chronic diseases. Biochemically, fasting leads to an activation of metabolic mechanisms designed to preserve carbohydrates and increase the dependence on energy produced by the metabolism of fat. There is little scientific evidence regarding the number of meals per day that proves to be the healthiest, and those studies that do exist have opposing conclusions. Several theories do exist regarding the number of meals per day that affect us in the most favorable way, but these are just theories. Our study is the first to assess, in both a systematic and controlled setting, how long-term, intermittent fasting affects the human body.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date June 2013
Est. primary completion date June 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria:

- Physically active, defined as at least 8,000 steps per day

- Regular meal frequency, i.e. energy intake=energy utilized, and eating between 3-6 meals per day

Exclusion Criteria:

- Daily medications

- Acute illness within the past two weeks (infection, fever, or surgery)

- Chronic disease, including cancer, heart, liver, kidney, and respiratory diseases, as well as metabolic diseases, such as diabetes

- Alcohol abuse or more than 14/21 units (women/men) consumed per week

- Smoking, including occasional smoking

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Behavioral:
Intermittent fasting - the effect on glucose metabolism, body composition and cognitive function
Each of the 10 subjects must through a period of monitoring (four weeks) before the study period (four weeks). Before, during, and after both the monitoring period and the study period, the subjects will undergo tests at Rigshospitalet. DAY 1: Inclusion and exclusion of subjects DAY 1 to DAY 28: Monitoring period (usual lifestyle) 28 days of dietary monitoring 28 days measurement by pedometer DAY 1, DAY 28 & DAY 56: Test 1 Oral glucose tolerance test with stable isotopes Fat and muscle biopsies DAY 2, DAY 29 & DAY 57: Test 2 DXA scanning Resting Metabolic Rate Measurement VO2max test on bicycle Cognitive testing MRI of the brain and abdomen DAY 9, DAY 19, DAY 38 & DAY 48: Test 3 Actiheart for 3 days 72-hour blood glucose monitoring with CGMS System DAY 29 to DAY 57: INTERVENTION Fasting from 7am - 9pm 28 days of dietary monitoring 28 days measurement by pedometer

Locations

Country Name City State
Denmark Centre of Inflammation and Metabolism, Rigshospitalet Copenhagen OE Copenhagen

Sponsors (1)

Lead Sponsor Collaborator
Inge Holm

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary oral glucose tolerance test and cognitive function OGTT with stable isotopes. To see the effect of plasma glucose mmol/L and plasma insulin pmol/L 1 month after intervention (2 months from beginning of the study).
Before, during, and after the intervention the subjects will complete cognitive tests for e.g. concentration, mood and appetite.
2 months No
Secondary Continuous glucose monitoring (CGM), body composition, and physical activity. During the control period and the intervention the CGM system will measure the continuous glucose concentration (each 5 min), and thereby any change will be measured. Before, during, and after the intervention the subjects body composition will be determined by weight, hip, waist, and with DXA and MRI scans. Furthermore, physical activity will be assessed by Actiheart and VO2 max tests. 2 months No
See also
  Status Clinical Trial Phase
Completed NCT04647149 - Effects of Early and Delayed Time-restricted Eating in Adults With Overweight and Obesity N/A
Completed NCT04953650 - Intermittent Fasting Towards Elevated Blood Pressure N/A
Active, not recruiting NCT05290233 - Time Restricted Eating Plus Exercise for Weight Management N/A
Completed NCT04404413 - High-Intensity Interval Training and Intermittent Fasting on Body Composition and Physical Performance in Active Women N/A
Recruiting NCT05558423 - ZOE Health Study: The Intermittent Fasting Study N/A
Completed NCT02770313 - Weekly ONe-Day WatER-only Fasting InterventionaL Trial for Low-Density Lipoprotein Cholesterol Reduction N/A
Active, not recruiting NCT05344066 - Manchester Intermittent Diet in Gestational Diabetes Acceptability Study N/A
Not yet recruiting NCT06330610 - Evaluation of the Efficiency of Intermittent Enteral Nutrition on Multi-organ Failure From Patients With Mechanical Ventilation in Intensive Care Unit N/A
Not yet recruiting NCT06299020 - Risks of Intermittent Fasting in Patients With Primary Adrenal Insufficiency N/A
Recruiting NCT03789409 - Intermittent Fasting Following Acute Ischemic Stroke N/A
Not yet recruiting NCT06302231 - Effects of Time-restricted Eating and Aerobic Exercise Training in Women With Overweight and Obesity N/A
Recruiting NCT05760339 - Intermittent Fasting Versus Carbohydrate Drinks Before Surgery N/A
Recruiting NCT06429124 - Time Restricted Eating in Alzheimer's Disease (TREAD) N/A
Enrolling by invitation NCT06105372 - Ramadan Fasting, Microbiota and FABP4
Completed NCT04732130 - Monitoring During Different Intermittent Fasting Protocols in Non-Obese Adults N/A
Completed NCT05422391 - The Acute Effects of Caloric Restriction on Anthropometrics, Metabolism, and Cardiovascular Health in Overweight Adults N/A
Recruiting NCT05136313 - Healthy vs Unhealthy Obesity: Mehanistic Insights and Effects of Time-Restricted Eating N/A
Not yet recruiting NCT06323889 - Longitudinal Monitoring During Intermittent Fasting Protocols in Obese Adults N/A
Recruiting NCT04873648 - Effect of Fasting and Calorie-Restricted Diets on Dopamine and Serotonin Levels Among Obese Women With BED and FA N/A
Recruiting NCT06174259 - Influence of Intermittent Fasting on Locally Advanced Breast Cancer Patients N/A